WisdomTreeHealthWDNA · Cboe BZX

WisdomTree BioRevolution Fund (WDNA)

Compare categoryCompare Health Care ETFs Compare with others

Price: $22.79; —12 Nov 2026
Assets: $5.1M; Total net assets
Expense ratio: 0.45%; Category 1.00%
Yield: 3.20%; Trailing distributions

1Y return: 41.7%+17.9%; Category 23.8%
3Y CAGR: 19.7%-0.5%; Category 20.2%
5Y CAGR: -0.8%-4.7%; Category 3.9%

$22.79—12 Nov 2026

Fund

Assets: $5.1M
Expense: 0.45%
Categ. exp: 1.00%
Yield: 3.20%

ReturnFundCateg.

1Y41.7%23.8%

3Y19.7%20.2%

5Y-0.8%3.9%

Launch-0.5%—

Loading NAV history…

WisdomTree BioRevolution Fund

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	+0.5%	+7.4%	+28.7%	+35.0%	+41.7%	+19.7%	-0.8%	—	-0.5%
Health average	6.4%	4.0%	21.1%	20.0%	23.8%	20.2%	3.9%	10.1%	11.2%
Difference	-5.9%	+3.4%	+7.6%	+15.0%	+17.9%	-0.5%	-4.7%	—	-11.7%

Holdings

The 10 largest positions make up 41.7% of the fund.

Top holdings

Largest holdings by weight
Ticker	Holding	Weight
MRNA	Moderna Inc	9.89%
TWST	Twist Bioscience Corp	9.68%
TXG	10x Genomics Inc Ordinary Shares - Class A	3.70%
LLY	Eli Lilly and Co	3.40%
NTRA	Natera Inc	3.08%
TEM	Tempus AI Inc Class A common stock	2.80%
JNJ	Johnson & Johnson	2.67%
IOVA	Iovance Biotherapeutics Inc	2.38%
UTHR	United Therapeutics Corp	2.10%
IMNM	Immunome Inc Ordinary Shares	1.99%

Portfolio valuation

Weighted averages of what the fund holds.

P/E: —
P/B: 4.6
P/S: 4.3
P/CF: —

Sector allocation

Share of the equity the fund holds.

Health care91.2%
Materials5.4%
Consumer staples3.4%

Asset mix

Stocks99.8%
Cash0.2%

ETF details

Issuer: WisdomTree
Category: Equity · Health
Ticker: WDNA
Exchange: Cboe BZX
Inception: 1 Jun 2021 (5.4 years)
Structure: Exchange Traded Fund
Expense ratio: 0.45% (category 1.00%)
Holdings turnover: 44% (category 51%)
Distribution yield: 3.20%
Beta, 3 years: 1.08
Total net assets: $5.1M

Prices and returns as of 12 Nov 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other health ETFs

Other ETFs in the Health category.

Compare Health Care ETFs